"A randomized, controlled trial comparing the immunogenicity of 2 doses vs 3 doses of the 9-valent HPV vaccine in females 27-45 years of age"

Project: Research project

Project Details

StatusActive
Effective start/end date8/31/228/30/26

Funding

  • Cancer Prevention and Research Institute: $498,409.00